Cannabinoids reduce ErbB2-driven breast cancer progression through AKT inhibition.
- Link to the original study.
- Online publication via NCBI PubMed Labs.
- Journal publication via Molecular Cancer 9, 196, July 22, 2010.
- Research via Complutense University, Madrid, Spain
